These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 17586614)

  • 1. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
    Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
    Sowers JR; Whaley-Connell A; Epstein M
    Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of aldosterone and angiotensin II in insulin resistance: an update.
    Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
    Whaley-Connell A; Johnson MS; Sowers JR
    Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
    Henriksen EJ; Prasannarong M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system.
    Henriksen EJ
    Am J Physiol Regul Integr Comp Physiol; 2007 Sep; 293(3):R974-80. PubMed ID: 17581838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.
    Zhou MS; Schulman IH; Raij L
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H833-9. PubMed ID: 19151253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New trends in insulin resistance: the role of mineralocorticoids.
    Lastra-Gonzalez G; Manrique-Acevedo C; Sowers JR
    J Cardiometab Syndr; 2007; 2(4):233-4. PubMed ID: 18059203
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
    Hayashi T; Takai S; Yamashita C
    Curr Vasc Pharmacol; 2010 Mar; 8(2):189-97. PubMed ID: 19485896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act.
    Muniyappa R; Yavuz S
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):59-69. PubMed ID: 22684034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of aldosterone in cardiovascular disease in people with diabetes and hypertension: an update.
    Lastra-Gonzalez G; Manrique-Acevedo C; Sowers JR
    Curr Diab Rep; 2008 Jun; 8(3):203-7. PubMed ID: 18625117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome.
    Leung PS; de Gasparo M
    J Cardiometab Syndr; 2006; 1(3):197-203. PubMed ID: 17679833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
    Bender SB; McGraw AP; Jaffe IZ; Sowers JR
    Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and the cardiometabolic syndrome.
    Manrique C; Lastra G; Whaley-Connell A; Sowers JR
    J Clin Hypertens (Greenwich); 2005 Aug; 7(8):471-6. PubMed ID: 16103758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction.
    Jing F; Mogi M; Horiuchi M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):23-8. PubMed ID: 22465098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.
    Zhou MS; Schulman IH; Zeng Q
    Vasc Med; 2012 Oct; 17(5):330-41. PubMed ID: 22814999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.
    Lastra G; Dhuper S; Johnson MS; Sowers JR
    Nat Rev Cardiol; 2010 Oct; 7(10):577-84. PubMed ID: 20697411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?
    Engeli S; Schling P; Gorzelniak K; Boschmann M; Janke J; Ailhaud G; Teboul M; Massiéra F; Sharma AM
    Int J Biochem Cell Biol; 2003 Jun; 35(6):807-25. PubMed ID: 12676168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress.
    Ferder L; Inserra F; Martínez-Maldonado M
    Curr Hypertens Rep; 2006 Jun; 8(3):191-8. PubMed ID: 17147916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.